The WARTS gene encodes a kinase that localizes to the mitotic apparatus of a dividing cell. Named WARTS after the growths that develop in the eyes of Drosophila in which the gene is deleted. WARTS is also implicated as a tumor suppressor in mice and humans. In this issue of Oncogene, Iida et al. describe experiments suggesting that, in addition to a role in regulating mitosis, WARTS functions to prevent further rounds of DNA synthesis and mitosis in tetraploid cells. As well as opening up new possibilities of exploring the as yet ill-defined mechanistic basis of the tetraploidy checkpoint, the involvement of a tumor-suppressor gene in this checkpoint supports its importance as a safeguard against the acquisition of genomic instability, a key event in the progression to cancer. Acquisition of genomic instability represents a key step in carcinogenic progression. The ensuing increase in genomic plasticity allows a cancer cell to rapidly acquire mutations that endow it with a proliferative advantage in the rapidly changing microenvironment of an emerging neoplasm. The most common manifestation of genomic instability in solid tumors is aneuploidy, which results from gains and losses of entire chromosomes as a consequence of abnormal mitoses. Aneuploidy is often thought to originate from a tetraploid intermediate that can arise as a consequence of mitotic defects. If tetraploid cells are able to re-enter the cell division cycle and complete cell division, aneuploidy is a likely and treacherous outcome. Hence normal cells possess a robust, yet mechanistically poorly defined safeguard mechanism, the tetraploidy checkpoint, which restricts cell cycle re-entry of tetraploid cells.
Cells that become arrested in metaphase for prolonged periods of time eventually progress into a normally permanent G1-like state. Since they replicated their genomes but did not complete nuclear and/or cellular division, such cells have tetraploid genomes. Even if a tetraploid cell re-enters the cell division cycle and becomes increasingly polyploid, it does not necessarily pose a clear and present danger to the organism, provided it remains incapable of completing subsequent mitoses and/or cell divisions. Consistent with this notion, polyploid cells are also generated during normal development. Tetraploid and polyploid cells can arise from cellular abnormalities such as lack of functional p53 or p21 CIP1 , which induce permanent cytokinesis defects. However, such cells are eliminated at a high frequency from the cellular proliferative pool by apoptosis or other mechanisms like cellular senescence (Bunz et al., 1998; Duensing et al., 2001) .
Since chromosomes and centrosomes are duplicated in synchrony, tetraploid cells contain two centrosomes. Hence, if a tetraploid cell re-enters the cell division cycle, it will contain four centrosomes during mitosis. Since each centrosome can act as a mitotic spindle pole body, it is likely that such a tetraploid cell will enter an abnormal, multipolar mitosis, whereby the chromosomes may not properly segregate. If such a cell can complete cytokinesis and cell division, the resulting daughter cells are likely to be aneuploid. The majority of such aneuploid offspring are almost certainly not viable and thus will not continue to proliferate. Gains (or losses) of some specific chromosomes however may provide a growth advantage and generate the proverbial 'one renegade cell' (Weinberg, 1998) , which forms the seed for the development of a neoplasm (reviewed in Storchova and Pellman, 2004) . Hence, studies on the tetraploidy checkpoint that blocks tetraploid cells from re-entering the cell cycle and thwarts the generation of genomic instability via such a mechanism are of exceptional importance for our understanding of tumor development and progression.
The paper by Iida et al. (2004) published in this issue of Oncogene offers some interesting and novel insights into the mechanistic basis of the tetraploidy checkpoint and how it might be connected to mitotic progression. This group has been investigating a human orthologue of the Drosophila tumor-suppressor warts (wts), also referred to as lats (large tumor suppressor), which was isolated from a mitotic recombination screen in somatic cells. Deletion of this gene causes an overgrowth phenotype (hyperproliferation without affecting pattern formation) in the Drosophila compound eye (Justice et al., 1995) , which results in the formation of large 'wart-like' cell masses that are in some ways reminiscent of human tumors. Given the mutant phenotype, one might speculate that wts regulates proliferation, differentiation and/or cell death. Sequence analysis of the wts gene revealed that it encodes a member of a family of evolutionarily conserved myotonic dystrophy protein kinases (DMPK) that are known to be involved in regulating various mitotic processes (Justice et al., 1995) . Two human wts-related genes have been described, one of which, WARTS (also termed LATS1), can fully rescue the phenotype of the wts mutation in Drosophila. Thus, it has been speculated that the human WARTS gene may also function as a tumor suppressor. Consistent with this notion, WARTS knockout mice exhibit an increased susceptibility to soft tissue sarcomas and ovarian tumors (St John et al., 1999) . A missense point mutation in WARTS was also discovered in a human soft tissue sarcoma, and hence human WARTS may indeed have tumor suppressor activity (Hisaoka et al., 2002) . Based on its localization to the cytoplasm and centrosomes in interphase cells, to the mitotic apparatus including the mitotic spindle poles and microtubules during metaphase/anaphase and to the midzone during telophase, WARTS may be classified a member of the 'chromosomal passenger' family of proteins.
A second wts-related human gene, termed LATS2 or kpm, has also been identified. Even though it has not been studied in much detail yet, it appears to have biochemical and biological activities similar to those of WARTS.
In their paper, Iida and colleagues present their studies on the function of the kinase activity of WARTS. WARTS undergoes autophosphorylation and the authors show that WARTS kinase activity peaks during early metaphase. To investigate the biological relevance of this mitosis-specific WARTS kinase activation, the authors constructed a kinaseinactive WARTS mutant and expressed it ectopically in the rat-1 fibroblast cell line. The subcellular localization of this mutant was indistinguishable from that of the wild-type protein, supporting the notion that WARTS autophosphorylation does not contribute to localization to the mitotic apparatus. Expression of this mutant in rat-1 cells, however, caused a prolonged delay in anaphase entry, presumably due to activation of the mitotic spindle assembly checkpoint, and the cells became tetraploid. Intriguingly, however, these cells did not efficiently arrest in a tetraploid state, but were able to undergo additional rounds of DNA synthesis and their ploidy increased over time. Hence the authors speculate that, in addition to regulating mitosis, WARTS may also act as a component of the elusive tetraploidy checkpoint (Iida et al., 2004) . This is a potentially exciting finding that not only implicates WARTS as a component of a regulatory circuit that engages the tetraploidy checkpoint in response to mitotic dysfunction, but also supports the notion that functional loss of the tetraploidy checkpoint constitutes a molecular defect that may facilitate carcinogenic progression. In addition, this study also poses a number of interesting questions. First, it will be important to follow the ploidy of these WARTS kinaseinactive mutant-expressing rat-1 cells over extended periods of time. Do these cells eventually become aneuploid and maybe even transformed? One might predict this to not be the case, since these cells would presumably encounter cytokinesis problems every time they attempted to undergo cell division. Nevertheless, such experiments would allow testing of the attractive model that tetraploidy could indeed be a precursor to aneuploidy. Such studies should ideally be performed in normal diploid human cells rather than in established rodent fibroblast lines, since these may have already accumulated some genetic alterations. These studies by Iida et al. also make the strong and testable prediction that Drosophila 'tumor' cells caused by wts loss will exhibit ploidy defects, and similarly the soft tissue sarcomas or ovarian tumors that arise in warts knockout mice will show evidence of poly-or aneuploidy. In addition, since WARTS is part of a multiprotein complex, the effect of expressing the kinase-inactive WARTS mutant on other components of this complex will need to be investigated.
It is interesting to note that another group has recently published a conceptually similar study with LATS2 (kpm), the other wts-related human protein. They performed their experiments by tetracyclineregulated expression of the wild-type or a kinaseinactive version of LATS2 in the HeLa human cervical carcinoma cell line. In contrast to WARTS, overexpression of the wild-type LATS2 protein caused a G2/M arrest and cell death, whereas expression of the kinase-inactive mutant showed no discernable effect on cell cycle progression or viability (Kamikubo et al., 2003) . HeLa cells are aneuploid, since they express the HPV-18 E6 and E7 oncoproteins that are known to subvert various aspects of cell cycle control and genomic stability (Duensing and Mu¨nger, 2002) . Thus the tetraploidy checkpoint could not be specifically analysed in this study.
The disparate effects on cell cycle progression and viability observed by expression of wild-type and kinaseinactive WARTS and LATS2 in these two studies may be explained by the different cell types that were used. It will be important to determine whether these results are recapitulated when WARTS and LATS2 and their kinase-defective mutants are expressed side-by-side and from isogenic vectors in normal human cells. If these two studies are taken at face value, though, one may conclude that WARTS and LATS2 might play opposite roles in regulating mitosis, apoptosis and potentially the tetraploidy checkpoint.
The biological activities and subcellular localization of human WARTS and LATS2 proteins are strikingly similar to what has been reported for survivin, another 'chromosomal passenger' that regulates mitosis as well as apoptosis. Survivin is a member of the inhibitor of apoptosis (IAP) family of proteins and is frequently overexpressed in human tumors. It may contribute to the malignant phenotype by rendering cells less sensitive to apoptosis by cytotoxic cytokines such as tumor necrosis factor a. Similar to what has been reported for expression of kinase-defective WARTS, inhibition of survivin expression causes profound cytokinesis and ploidy defects (reviewed in Altieri, 2003) . Studies in Drosophila showed that wts could affect expression of the survivin-related Drosophila inhibitor of apoptosis 1 protein (DIAP1). Wts forms a complex with Salvador (Sav) and the Ste20-related kinase Hippo (Hpo). The wts-Sav-Hpo complex phosphorylates molecules that negatively regulate DIAP1 and cyclin E expression (reviewed in Hay and Guo, 2003) . The human WARTS and LATS2 gene products may form similar complexes with human salvador and hippo proteins, and thus it will be exciting to investigate whether there may be a connection between the WARTS/LATS2 and survivin pathways. Similarly, the ability of wts to regulate cyclin E expression may merit some experimental attention with respect to tetraploidy checkpoint regulation, particularly since ectopic cyclin E expression has been reported to cause genomic instability (Spruck et al., 1999) .
Pioneering studies by Elisabeth Gateff's group showed that loss of genomic material can lead to the formation of invasive, transplantable malignancies in Drosophila (reviewed in Gateff, 1994) , and provided some of the original clear experimental support for the existence of defined genetic elements that can act as tumor suppressors. Even though there appears to be only minimal overlap between molecules that have been identified as tumor suppressors in Drosophila and tumor suppressors that contribute to human cancers, studies of Drosophila tumor suppressors and their human counterparts have led to the identification of important regulatory principles of cell growth, differentiation and apoptosis, and, as illustrated by Iida and colleagues, continue to have a major impact on cancer biology.
